Relevium is a publicly traded corporation strategically focused the acquisition of e-retail brands, products and technologies in the health and wellness market, with specific interest in Overall Health, Nutraceuticals, Fitness Nutrition and Cosmeceuticals.

1. TSXV: RLV ● FRA: 6BX
August 22, 2017

2. DISCLAIMER
THIS DOCUMENT HAS BEEN PREPARED BY RELEVIUM TECHNOLOGIES INC. (THE “COMPANY”) SOLELY FOR INFORMATION PURPOSES. THIS
DOCUMENT DOES NOT CONSTITUTE AN OFFERING DOCUMENT. THIS DOCUMENT IS THE SOLE RESPONSIBILITY OF THE COMPANY. INFORMATION
CONTAINED HEREIN DOES NOT PURPORT TO BE COMPLETE AND IS SUBJECT TO CERTAIN QUALIFICATIONS AND ASSUMPTIONS AND SHOULD NOT
BE RELIED UPON FOR THE PURPOSE OF MAKING AN INVESTMENT IN THE COMPANY’S SECURITIES OR ENTERING INTO ANY TRANSACTION IN
RELATION THEREWITH. THE INFORMATION AND OPINIONS CONTAINED IN THIS DOCUMENT ARE PROVIDED AS AT THE DATE HEREOF AND ARE
SUBJECT TO CHANGE WITHOUT NOTICE AND, IN FURNISHING THIS DOCUMENT, THE COMPANY DOES NOT UNDERTAKE OR AGREE TO ANY
OBLIGATION TO PROVIDE RECIPIENTS WITH ACCESS TO ANY ADDITIONAL INFORMATION OR TO UPDATE OR CORRECT THE DOCUMENT. THIS
DOCUMENT, NOR HAS IT REVIEWED THIS DOCUMENT.
FORWARD LOOKING INFORMATION
CERTAIN OF THE INFORMATION CONTAINED IN THIS PRESENTATION MAY CONTAIN “FORWARD-LOOKING INFORMATION”. FORWARD-LOOKING
INFORMATION AND STATEMENTS MAY INCLUDE, AMONG OTHERS, STATEMENTS REGARDING THE FUTURE PLANS, COSTS, OBJECTIVES OR
PERFORMANCE OF THE COMPANY, OR THE ASSUMPTIONS UNDERLYING ANY OF THE FOREGOING. IN THIS PRESENTATION, WORDS SUCH AS
“MAY”, “WOULD”, “COULD”, “WILL”, “LIKELY”, “BELIEVE”, “EXPECT”, “ANTICIPATE”, “INTEND”, “PLAN”, “ESTIMATE” AND SIMILAR WORDS AND THE
NEGATIVE FORM THEREOF ARE USED TO IDENTIFY FORWARD-LOOKING STATEMENTS. FORWARD-LOOKING STATEMENTS SHOULD NOT BE READ
AS GUARANTEES OF FUTURE PERFORMANCE OR RESULTS, AND WILL NOT NECESSARILY BE ACCURATE INDICATIONS OF WHETHER, OR THE TIMES
AT OR BY WHICH, SUCH FUTURE PERFORMANCE WILL BE ACHIEVED. FORWARD-LOOKING STATEMENTS AND INFORMATION ARE BASED ON
INFORMATION AVAILABLE AT THE TIME AND/OR MANAGEMENT’S GOOD-FAITH BELIEF WITH RESPECT TO FUTURE EVENTS AND ARE SUBJECT TO
KNOWN OR UNKNOWN RISKS, UNCERTAINTIES, ASSUMPTIONS AND OTHER UNPREDICTABLE FACTORS, MANY OF WHICH ARE BEYOND THE
COMPANY’S CONTROL. THE COMPANY DOES NOT INTEND, NOR DOES THE COMPANY UNDERTAKE ANY OBLIGATION, TO UPDATE OR REVISE ANY
FORWARD-LOOKING INFORMATION OR STATEMENTS CONTAINED IN THIS PRESENTATION TO REFLECT SUBSEQUENT INFORMATION, EVENTS OR
CIRCUMSTANCES OR OTHERWISE, EXCEPT IF REQUIRED BY APPLICABLE LAWS.

3. TSXV:RLV ● FRA:6BX
WHO IS RLV
3
RLV is primarily an acquisition company
Build a portfolio of brands in Health & Wellness
Razor sharp focus on e-commerce

4. TSXV:RLV ● FRA:6BX
HOW RLV CREATES
VALUE
4
Acquire profitable brands at favorable multiples
Invest in optimization and brand awareness
Leverage technology and combine to secure
higher multiples

5. TSXV:RLV ● FRA:6BX 5
Kristine Dorward - Director
• Director Marketing and Development, ProMetic
Life Sciences
• Biotech and Pharma
• Strength: Branding Strategy
Andre Godin - Chairman
• EVP & CFO, IntelGenx Corp
• Biotech and Pharma
• Strength: Finance & Strategy
Pierre Bertrand - Director
• CEO, Essilor Canada
• Biotech, Pharma and Consumer Products
• Strength: Mergers & Acquisitions
Tina Sampalis, - Director
• President, Vanguard Strategic
Consulting
• Medicine, Biotech and Pharma
• Strength: Product Development
Michel Timperio - Director
• VP Strategic Development, Neptune
Technologies
• Biotech and Pharma
• Strength: Business Development
Ted Zablotsky, MD - Director
• Medical Doctor and Researcher
• Medicine and Pain Management
• Strength: IP Development
EXPERIENCED LEADERSHIP
Aurelio Useche – CEO
• Green-tech, Technology and Natural
Resources and
• Strength: Strategy and Operations
Management

6. TSXV:RLV ● FRA:6BX
SOLID MARKETPLACE
6
Source: http://www.businessinsider.com/e-commerce-disrupting-health-and-personal-care-market-2015-4
HEALTH AND WELLNESS
MARKET
ü A Worldwide $3.7 Trillion Industry
ü Less than 10% of sales online vs.
20-30% in other segments
ü Online Business Estimated to grow
17% per year

7. TSXV:RLV ● FRA:6BX
RLV ACQUISITION STRATEGY
7
PROFILE AND RISK
ü Brands with revenues between $2M -
$20M
ü Average 4X EBIT
ü Shared Transaction Risk
STRATEGIC OUTCOME
ü Accrete Talent
ü Build Brand Awareness across platforms &
geographies
ü Drive efficiencies through economies of
scale

8. TSXV:RLV ● FRA:6BX
M&A PIPELINE
8
PIPELINE DETAILS
§ Supports Roll-Up Strategy
§ Average EBIT of 31%
§ Acquisition Multiple 4.4
(Avg)

9. TSXV:RLV ● FRA:6BX 9
HEALTH & WELLNESS
Supplements
Mind and Body
Nutrition
Natural Health
Skin Care
RLV BRAND STRATEGY
Active Life

10. TSXV:RLV ● FRA:6BX
BIOGANIX ACQUISITION
10
Website
www.bioganix.com
Financial Summary
TTM Gross Revenue $5M
CAD
TTM Cash Flow
$1.3M CAD
Ecommerce Sales
Channel: Amazon (90%)
Direct: Shopify (10%)
Closed
June 6 2017
Purchase Price
$5.8M CAD (3.7X EBIT)
Website Properties
Formulations
Inventory
Product Pipeline
Purchase Terms
• $2.6M Cash at Closing
• $675K Stock at Closing
• $675K Cash in 12 months
• $2.1M VTB (2yr Note)

11. TSXV:RLV ● FRA:6BX
BIOGANIX FIRST 60-DAYS
11
Successfully integrated
operations
Platform optimization
underway
Sales 58% vs. last year
with positive cash flows

12. TSXV:RLV ● FRA:6BX
WHAT TO EXPECT: BIOGANIX
12
LAUNCHING Fitness Nutrition Brand
LEVERAGING exclusivity with
HEMPCO to launch a Vegan Brand
LICENSE of IP-Based Nutraceutical and
add to existing brand

13. TSXV:RLV ● FRA:6BX
WHAT TO EXPECT: M&A
13
ONE ACQUISITION EVERY SIX MONTHS
1. Acquisition Value (AVG): $7M
2. Cash on Closing: 50-60%
3. Debt-Equity Financing: 3/2
4. AVG EBIT Cost 4X
5. AVG Market Val 7X

14. TSXV:RLV ● FRA:6BX
MARKET COMPARABLES
14

15. TSXV:RLV ● FRA:6BX
WHAT TO EXPECT: TECHNOLOGY
15

16. TSXV:RLV ● FRA:6BX
CORPORATE PROFILE
16
GENERAL INFORMATION
Sector: Consumer Healthcare
Ticker Symbol “RLV-V”
Headquarters: Montreal
TRADING INFORMATION
Stock Price: $0.10 / Market Cap: $6.5M
120-day Volume: 351K shares
52-week Range: $0.05-0.22
120 Day VWAP: $0.14
CAPITAL
STRUCTURE
Shares O/S: 65M
Options (@0.14): 3M
Warrants (@0.15): 41M
Shares F/D: 110M
KEY HOLDINGS
Insiders: 33%
Escrowed: 14%
Free Trading: 46%

17. Renmark Financial Communications Inc.
Steve Hosein
(416) 644-2020 or (514) 939-3989
shosein@renmarkfinancial.com
www.renmarkfinancial.com
Relevium Technologies Inc.
Aurelio Useche
(888)-528-8687
investors@releviumcorp.com
www.releviumtechnologies.com
TSXV: RLV